1Globe Capital LLC - Oct 7, 2025 SCHEDULE 13G/A Report for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share

Filing Manager: 1Globe Capital LLC
Reporting Manager: 1Globe Capital LLC
Security: Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share
Shares outstanding: 13.8M shares
Disclosed Ownership: 1.43M shares
Ownership: 10.3%
Form type: SCHEDULE 13G/A
Date filed: 10/14/2025, 03:41 PM
Date of event: Oct 7, 2025
Previous filing: Aug 20, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
1Globe Capital LLC	10.3%	1.43M	0	1.43M	/s/ Jiaqiang Li	Chairman
Jiaqiang Li	10.3%	1.43M	0	1.43M	/s/ Jiaqiang Li	Reporting person